Molecular docking of 2-(benzimidazol-2-ylthio)-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor 1

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Molecular Modeling

• Publication date

  2012-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00894-011-1307-xPMID 22127612PMCID PMC3314724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Classification and regression trees

  2012cited by this paper
• N-Formyl-Methionyl-Leucyl-Phenylalanine (fMLP) Promotes Osteoblast Differentiation via the N-Formyl Peptide Receptor 1-mediated Signaling Pathway in Human Mesenchymal Stem Cells from Bone Marrow*

  2011cited by this paper
• Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment.

  2011cited by this paper
• Gastrin-Releasing Peptide/Neuromedin B Receptor Antagonists PD176252, PD168368, and Related Analogs Are Potent Agonists of Human Formyl-Peptide Receptors

  2011cited by this paper
• Comparison of three GPCR structural templates for modeling of the P2Y12 nucleotide receptor

  2011cited by this paper
• What Formyl Peptide Receptors, if Any, Are Triggered by Compound 43 and Lipoxin A4?

  2011cited by this paper
• Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists.

  2010cited by this paper
• Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus.

  2010cited by this paper
• The Agonists of Formyl Peptide Receptors Prevent Development of Severe Sepsis after Microbial Infection

  2010cited by this paper
• Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia–reperfusion injury?

  2010cited by this paper
• Identification of Novel Small-Molecule Agonists for Human Formyl Peptide Receptors and Pharmacophore Models of Their Recognition

  2010cited by this paper
• The Annexin I Sequence Gln9-Ala10-Trp11-Phe12 Is a Core Structure for Interaction with the Formyl Peptide Receptor 1*

  2010cited by this paper
• Neutrophil apoptosis: A target for enhancing the resolution of inflammation

  2009cited by this paper
• International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family

  2009cited by this paper
• Combining docking, molecular dynamics and the linear interaction energy method to predict binding modes and affinities for non-nucleoside inhibitors to HIV-1 reverse transcriptase.

  2008cited by this paper
• 3-Dimensional structures of G protein-coupled receptors and binding sites of agonists and antagonists.

  2007cited by this paper
• Neutrophil isolation from nonhuman species.

  2007cited by this paper
• Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.

  2007cited by this paper
• Ligand‐supported homology modeling of the human angiotensin II type 1 (AT1) receptor: Insights into the molecular determinants of telmisartan binding

  2006cited by this paper
• Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses.

  2006cited by this paper
• Pharmacophore model for bile acids recognition by the FPR receptor

  2006cited by this paper
• Resolution of in flammation: state of the art, definitions and terms

  2006cited by this paper
• Chemotactic peptides: fMLF-OMe analogues incorporating proline-methionine chimeras as N-terminal residue.

  2006cited by this paper
• Integration of Virtual Screening with High-Throughput Flow Cytometry to Identify Novel Small Molecule Formylpeptide Receptor Antagonistss⃞

  2005cited by this paper
• Neutrophil NADPH‐oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors

  2005cited by this paper
• Phagocyte Activation by Trp–Lys–Tyr–Met–Val–Met, Acting through FPRL1/LXA4R, is not Affected by Lipoxin A4

  2002cited by this paper
• The conformational switch in muscarinic acetylcholine receptors.

  2001cited by this paper
• G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin.

  2001cited by this paper
• Characterization of the Binding Site on the Formyl Peptide Receptor Using Three Receptor Mutants and Analogs of Met-Leu-Phe and Met-Met-Trp-Leu-Leu*

  2000cited by this paper
• The ligand binding site of the formyl peptide receptor maps in the transmembrane region.

  1997cited by this paper
• Chemotactic Peptide Analogues Centrally Constrained Chemotactic N‐Formyltripeptides: Synthesis, Conformation, and Activity of Two New Analogues

  1997cited by this paper
• Elements of artificial neural networks

  1996cited by this paper
• The Importance of the Peptide Bond at Position 2 in HCO‐Met‐Leu‐Phe‐OMe Analogues as shown by Studies on Human Neutrophils

  1996cited by this paper
• The role of peptide bond in chemotactic for-Met-Leu-Phe-Ome focused by depsipeptide analogs

  1994cited by this paper
• Synthesis, conformation, and activity of HCO‐Met‐ΔZ Leu‐Phe‐Ome, an active analogue of chemotactic N‐formyltripeptides

  1993cited by this paper
• Discriminant Analysis and Statistical Pattern Recognition

  1992cited by this paper
• Classification and regression trees

  1983cited by this paper

• Formylpeptide receptors in GtoPdb v.2025.3

  2025cites this paper
• Formylpeptide receptors in GtoPdb v.2025.1

  2025cites this paper
• The formyl peptide receptors FPR1 and FPR2 as targets for inflammatory disorders: recent advances in the development of small-molecule agonists.

  2023cites this paper
• Synthesis and Biological Evaluation of Structurally Diverse Benzimidazole Scaffolds as Potential Chemotherapeutic Agents.

  2019cites this paper
• Formylpeptide receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• The investigation of structure–activity relationship of polyamine-targeted synthetic compounds from different chemical groups

  2019cites this paper
• 4‐Aroyl‐3‐hydroxy‐5‐phenyl‐1H‐pyrrol‐2(5H)‐ones as N‐formyl peptide receptor 1 (FPR1) antagonists

  2017cites this paper
• The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition

  2017influential citation
• Formyl peptide receptor polymorphisms: 27 most possible ways for phagocyte dysfunction

  2017cites this paper
• 2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists.

  2016cites this paper
• Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.

  2016cites this paper
• FPR2/ALXR agonists and the resolution of inflammation.

  2015cites this paper
• Adaptive Evolution of Formyl Peptide Receptors in Mammals

  2015cites this paper
• Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.

  2014cites this paper
• Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition.

  2014cites this paper
• Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists.

  2013cites this paper
• Selective agonists and antagonists of formylpeptide receptors: duplex flow cytometry and mixture-based positional scanning libraries

  2013cites this paper
• Synthesis and Pharmacological Evaluation of New Pyridazin‐Based Thioderivatives as Formyl Peptide Receptor (FPR) Agonists

  2013cites this paper
• 3-(1H-indol-3-yl)-2-[3-(4-nitrophenyl)ureido]propanamide enantiomers with human formyl-peptide receptor agonist activity: molecular modeling of chiral recognition by FPR2.

  2013cites this paper
• Selective Agonists and Antagonists of Formylpeptide Receptors: Duplex Flow Cytometry and Mixture-Based Positional Scanning Libraries

  2013cites this paper
• The Role of Water in Activation Mechanism of Human N-Formyl Peptide Receptor 1 (FPR1) Based on Molecular Dynamics Simulations

  2012cites this paper